GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scholar Rock Holding Corp (STU:2QK) » Definitions » Short Percentage of Float

Scholar Rock Holding (STU:2QK) Short Percentage of Float


View and export this data going back to 2019. Start your Free Trial

What is Scholar Rock Holding Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Scholar Rock Holding's Short Percentage of Float

For the Biotechnology subindustry, Scholar Rock Holding's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Scholar Rock Holding's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scholar Rock Holding's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Scholar Rock Holding's Short Percentage of Float falls into.


;
;

Scholar Rock Holding Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scholar Rock Holding Corp (STU:2QK) » Definitions » Short Percentage of Float
Comparable Companies
CRNX MRUS AKRO CRSP XENE SWTX CPRX VKTX PTGX ACLX VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
SRRK:USA 2QK:Germany
Address
301 Binney Street, 3rd Floor, Cambridge, MA, USA, 02142
Website
https://www.scholarrock.com
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

Scholar Rock Holding Headlines

No Headlines